Trending Tickers : Halliburton Company (NYSE:HAL), ArcelorMittal SA (ADR) (NYSE:MT), Columbia Property Trust, Inc. (NYSE:CXP), Coherent Inc. (NASDAQ:COHR), Endocyte, Inc. (NASDAQ:ECYT)

On Oct 21, As fracking accelerates in North American shale fields, oilfield services providers Halliburton Company (NYSE:HAL) and Baker Hughes Inc are stockpiling sand to protect themselves against rising costs and are buying more railcars to transport the haul. Halliburton Company (NYSE:HAL) belongs to Basic Materials sector. Its net profit margin is 10.70% and weekly performance is -1.00%. On last trading day company shares ended up $52.39. Halliburton Company (NYSE:HAL) distance from 50-day simple moving average (SMA50) is -16.79%.

On October 23, ArcelorMittal SA (ADR) (NYSE:MT) announces the publication of sell-side analysts’ consensus forecasts for ArcelorMittal’s third quarter 2014 Ebitda. ArcelorMittal SA (ADR) (NYSE:MT) shares moved down -2.70% in last trading session and ended the day at $12.59. MT return on assets is -1.50%. ArcelorMittal SA (ADR) (NYSE:MT) quarterly performance is -17.33%.

Columbia Property Trust (NYSE:CXP) Director John L. Dixon acquired 2,000 shares of the stock in a transaction dated Monday, September 15th. The shares were purchased at an average price of $25.07 per share, with a total value of $50,140.00. On 27 October, Columbia Property Trust, Inc. (NYSE:CXP) shares advanced 0.59% and was closed at $25.43. CXP EPS growth in last 5 year was 23.10%. Columbia Property Trust, Inc. (NYSE:CXP) year to date (YTD) performance is 5.30%.

On Oct. 16, Coherent Inc. (NASDAQ:COHR) announced that it plans to report its fourth quarter and fiscal year 2014 financial results after market close on November 4, 2014. Coherent Inc. (NASDAQ:COHR) ended the last trading day at $59.74. Company weekly volatility is calculated as 2.92% and price to cash ratio as 4.91. Coherent Inc. (NASDAQ:COHR) showed a weekly performance of 1.84%.

Citigroup Inc. restated their neutral rating on shares of Endocyte (NASDAQ:ECYT) in a report released on Monday. Citigroup Inc. currently has a $10.00 price objective on the stock, up from their previous price objective of $8.00. Endocyte, Inc. (NASDAQ:ECYT) shares advanced 0.52% in last trading session and ended the day at $5.84. ECYT return on assets is 7.50%. Endocyte, Inc. (NASDAQ:ECYT) quarterly performance is -4.58%.